References
Duchayne E, Demur C, Rubie H, Robert A, Dastugue N (1999) Diagnosis of acute basophilic leukemia. Leukemia & lymphoma 32(3–4):269–278. doi:10.3109/10428199909167387
Peterson LC, Parkin JL, Arthur DC, Brunning RD (1991) Acute basophilic leukemia: a clinical, morphologic, and cytogenetic study of eight cases. Am J Clin Pathol 96(2):160–170
Kritharis A, Brody J, Koduru P, Teichberg S, Allen SL (2011) Acute basophilic leukemia associated with loss of gene ETV6 and protean complications. J Clin Oncol 29(21):e623–e626. doi:10.1200/jco.2010.34.5710
Quelen C, Lippert E, Struski S, Demur C, Soler G, Prade N, Delabesse E, Broccardo C, Dastugue N, Mahon FX, Brousset P (2011) Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants. Blood 117(21):5719–5722. doi:10.1182/blood-2011-01-333013
Dastugue N, Duchayne E, Kuhlein E, Rubie H, Demur C, Aurich J, Robert A, Sie P (1997) Acute basophilic leukaemia and translocation t(X;6)(p11;q23). Br J Haematol 98(1):170–176
Hoyle CF, Sherrington P, Hayhoe FG (1988) Translocation (3;6)(q21;p21) in acute myeloid leukemia with abnormal thrombopoiesis and basophilia. Cancer Genet Cytogenet 30(2):261–267
Luo XH, Zhu Y, Tang XQ (2014) Acute basophilic leukemia presenting with maculopapular rashes and a gastric ulcer: a case report. Oncol Lett 8(6):2513–2516. doi:10.3892/ol.2014.2544
Swisher RW, Mueller JM, Halloran G (1978) Basophilic leukemia presenting as gastroduodenal ulceration: effect of H-2-receptor blockade. The American journal of digestive diseases 23(10):952–955
Giagounidis AA, Hildebrandt B, Heinsch M, Germing U, Aivado M, Aul C (2001) Acute basophilic leukemia. Eur J Haematol 67(2):72–76
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Fumihiko Nakamura has the following financial relationships to disclose. Honoraria (lecture fee) from Pfizer Inc. (idarubicin).
Mineo Kurokawa has the following financial relationships to disclose. Leadership position/advisory role for Shionogi Inc. (prednisolone). Research funding from Pfizer Inc. (idarubicin) and Nippon Shinyaku Co., LTD. (cytarabine). Honoraria (lecture fee) from Nippon Shinyaku Co., LTD. (cytarabine).
The other authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from the patient for being included in this case report.
Rights and permissions
About this article
Cite this article
Koya, J., Ibaraki, T., Yamazaki, I. et al. Acute basophilic leukemia with add(3)(q12) accompanied by histamine excess symptoms. Ann Hematol 96, 1197–1199 (2017). https://doi.org/10.1007/s00277-017-2987-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-017-2987-9